TABLE 1.

CGD patient characteristics and IFN-γ dose^a

Patient no.	Age (yr)/genderb	CGD typec	Dose of IFN-γ (μg/m2)
1	6/F	Autosomal, not defined	100
2	7/M	X910	50
3	17/M	X910	100
4	9/M	X910	50
5	17/M	X910	50
6	16/F	A670	50
7	33/M	A470	100
8	22/M	A470	50

^aNo patient had an oxidative capacity. 

^bF, female; M, male. 

^cThe numbers 91, 47, and 67 indicate the defective phox proteins. X, X-linked inheritance; A, autosomal recessive; superscript zero, undetectable protein on immunoblot.